tiprankstipranks
Iridex Corp (IRIX)
NASDAQ:IRIX
US Market

Iridex (IRIX) Earnings Dates, Call Summary & Reports

Compare
131 Followers

Earnings Data

Report Date
May 19, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
Last Year’s EPS
-0.1
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 26, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed meaningful operational progress and financial improvement: revenue growth, significant operating expense reductions, the company’s first positive adjusted EBITDA in recent history, and positive operating cash flow in the quarter. These positives are tempered by margin pressure from higher manufacturing costs and tariffs, inventory write-downs, and notable regional headwinds (Middle East, China, Japan) that constrained sales and led management to provide conservative guidance excluding the Middle East. Management outlined credible cost-saving initiatives (G&A relocations, HQ move, contract manufacturing transition) expected to improve margins over 2026–2027, but those benefits are multi-quarter in delivery and carry execution risk. Overall, the call emphasizes a clear operational turnaround with some material but manageable near-term risks.
Company Guidance
The company guided 2026 revenue of $51.0–$53.0 million (guidance assumes no Middle East sales — the Middle East was ~5% of total revenue and ~10% of U.S. revenue), which on a pro forma basis excluding 2025 Middle East revenue implies 1%–5% growth versus 2025 (FY2025 revenue was $52.7M, up 8% year-over-year); management reiterated seasonality (Q1 ~22% of annual revenue, Q4 strongest) and said it expects to generate positive cash flow for fiscal 2026 with cash generation improving after Q1. They forecast adjusted operating expenses (ex‑D&A and stock comp) of $19.0–$19.5M, plan to realize ~$165K of quarterly savings beginning Q1 2026 from G&A relocations (and an additional ~$600K annualized savings from a later HQ move), and expect gross-margin improvement as manufacturing transfers begin in 2026 (full transition by 2027). Recent financials cited to support the outlook included Q4 revenue of $14.7M (16% YoY), FY2025 adjusted EBITDA of $817K, cash and cash equivalents of ~$6.0M at quarter end, and 2025 cash use of $2.1M (a 71% improvement vs. 2024).
Full-Year Revenue Growth
Revenue for fiscal 2025 was $52.7 million, representing +8% year-over-year growth versus 2024, with broad-based growth across Cyclo G6, medical retina and surgical retina, and both U.S. and international businesses.
Strong Q4 Performance
Fourth-quarter revenue was $14.7 million, a +16% year-over-year increase (Q4 was a 14-week quarter), marking the strongest quarterly growth rate of the year and driven by higher retina and glaucoma probe sales.
Profitability and Cash Flow Milestones
IRIDEX delivered positive adjusted EBITDA for the full year (adjusted EBITDA $817,000 vs $611,000 prior year) and generated positive cash flow from operations in Q4. Net loss narrowed to $0.2 million (loss per share $0.01) vs $0.8 million in prior year.
Material Operating Expense Reductions and Cost Savings Plans
Operating expenses were reduced 22% year-over-year (full year); Q4 operating expenses totaled $5.5 million (a 10% reduction vs prior-year quarter). Actions include relocation of certain G&A functions (estimated ~$165k in quarterly savings beginning Q1 2026) and a planned HQ relocation expected to reduce fixed costs by ~$600k annually.
Product and Commercial Momentum
Glaucoma probe sales: Q4 probes sold 15,900 vs 13,300 prior-year (+~19%); full-year probes 57,800 vs 55,400 (+~4%). Full-year G6 systems sold 133 vs 125 (up ~6%). Retina revenue increased 22% in Q4 to $8.9 million driven by PASCAL and medical/surgical retina systems. Sales team converted ~$1.0M of business from the AAO meeting.
Improved Cash Position and Cash Usage
Cash and cash equivalents improved to approximately $6.0 million (up ~$400k from ~$5.6M) and cash use for 2025 was $2.1 million, an improvement of 71% versus 2024; management expects further cash generation and positive full-year cash flow in 2026.

Iridex (IRIX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IRIX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 19, 2026
2026 (Q1)
- / -
-0.1
Mar 26, 2026
2025 (Q4)
-0.02 / -0.01
-0.0580.00% (+0.04)
Nov 11, 2025
2025 (Q3)
- / -0.09
-0.1225.00% (+0.03)
Aug 12, 2025
2025 (Q2)
- / -0.06
-0.1662.50% (+0.10)
May 13, 2025
2025 (Q1)
- / -0.10
-0.2152.38% (+0.11)
Mar 27, 2025
2024 (Q4)
- / -0.05
-0.1872.22% (+0.13)
Nov 12, 2024
2024 (Q3)
-0.09 / -0.12
-0.11-9.09% (>-0.01)
Aug 08, 2024
2024 (Q2)
-0.12 / -0.16
-0.175.88% (+0.01)
May 14, 2024
2024 (Q1)
-0.12 / -0.21
-0.13-61.54% (-0.08)
Mar 26, 2024
2023 (Q4)
-0.05 / -0.18
-0.07-157.14% (-0.11)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IRIX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 11, 2025
$1.19$0.95-20.17%
Aug 12, 2025
$1.30$1.18-9.23%
May 13, 2025
$1.10$1.00-9.09%
Mar 27, 2025
$0.88$1.00+13.64%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Iridex Corp (IRIX) report earnings?
Iridex Corp (IRIX) is schdueled to report earning on May 19, 2026, After Close (Confirmed).
    What is Iridex Corp (IRIX) earnings time?
    Iridex Corp (IRIX) earnings time is at May 19, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IRIX EPS forecast?
          Currently, no data Available